Los puntos clave no están disponibles para este artículo en este momento.
This study estimates the global burden of epilepsy and the proportions with AE, which may benefit from treatment. There are systematic differences in reported prevalence estimates, which are only partially explained by study characteristics.
Ngugi et al. (Thu,) studied this question.